Evidence map›Paper›PMID 35512829›Full record

ArticleLife science alliance2022

miR-486 is essential for muscle function and suppresses a dystrophic transcriptome.

Adrienne Samani, Rylie M Hightower, Andrea L Reid, Katherine G English, Michael A Lopez, J Scott Doyle, Michael J Conklin, David A Schneider, Marcas M Bamman, Jeffrey J Widrick and 5 more

Open access · goldAbstract read
In one paragraph

Article in Life science alliance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Role of miRNA in Cardiovascular Diseases in Children-Systematic Review.International journal of molecular sciences · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Local Non-Coding Regulatory Elements in Muscular Dystrophies.International journal of molecular sciences · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Adrienne SamaniDepartment of Pediatrics, Division of Neurology at Children's of Alabama and the University of Alabama at Birmingham, Birmingham, AL, USA.
Rylie M HightowerDepartment of Pediatrics, Division of Neurology at Children's of Alabama and the University of Alabama at Birmingham, Birmingham, AL, USA.
Andrea L ReidDepartment of Pediatrics, Division of Neurology at Children's of Alabama and the University of Alabama at Birmingham, Birmingham, AL, USA.
Katherine G EnglishDepartment of Pediatrics, Division of Neurology at Children's of Alabama and the University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0003-2757-5157
Michael A LopezDepartment of Pediatrics, Division of Neurology at Children's of Alabama and the University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0002-3029-0761
J Scott DoyleDepartment of Orthopedic Surgery, at the University of Alabama at Birmingham, Birmingham, AL, USA.
Michael J ConklinDepartment of Orthopedic Surgery, at the University of Alabama at Birmingham, Birmingham, AL, USA.
David A SchneiderDepartment of Biochemistry and Molecular Genetics at the University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0003-0635-5091
Marcas M BammanUniversity of Alabama at Birmingham Center for Exercise Medicine (UCEM), Birmingham, AL, USA.
Jeffrey J WidrickDivision of Genetics and Genomics at Boston Children's Hospital, Boston, MA, USA.ORCID 0000-0002-5597-1141
David K CrossmanDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0002-0981-169X
Min XieDivision of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, School of Medicine, Birmingham, AL, USA.
David JeeDevelopmental Biology Program, Sloan Kettering Institute, New York, NY, USA.
Eric C LaiDevelopmental Biology Program, Sloan Kettering Institute, New York, NY, USA.ORCID 0000-0002-8432-5851
Matthew S AlexanderDepartment of Pediatrics, Division of Neurology at Children's of Alabama and the University of Alabama at Birmingham, Birmingham, AL, USA matthewalexander@uabmc.edu.ORCID 0000-0001-7406-5171
University of Alabama at Birmingham · USChildren's of Alabama · USCornell University · USBoston Children's Hospital · USCivitan International · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Why is the prevalence of obesity so high in U.S. Southern States? Regional predictors of BMI and obesity treatment response.P30DK056336 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARBARA A GOWER · 2000 to 2026
$31.9M
The Exercise and Physical Activity Collaborative Team (ExPACT): a Proposed MoTrPAC Clinical CenterU01AR071133 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BUFORD, THOMAS W, GOODPASTER, BRET H · 2017 to 2024
$16.7M
Selective regulatory and biogenesis mechanisms for microRNAsR01GM083300 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI Eric C Lai · 2007 to 2026
$9.8M
Rehabilitation Research Resource to Enhance Clinical Trials (ReACT)P2CHD086851 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BAMMAN, MARCAS M · 2015 to 2019
$7.1M
Molecular and genetic analysis of novel Slicer-dependent miRNA pathways in bloodR01HL135564 · NHLBI · SLOAN-KETTERING INST CAN RESEARCH · PI KHARAS, MICHAEL, LAI, ERIC C · 2017 to 2020
$2.9M
UNDERSTANDING THE ROLES OF RNA POLYMERASE I IN TRANSCRIPTION AND BEYONDR35GM140710 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHNEIDER, DAVID ALAN · 2021 to 2025
$2.1M
Enhancing Autophagy and Mitochondrial Biogenesis to Mitigate Cardiac Reperfusion InjuryR01HL153501 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI XIE, MIN · 2020 to 2024
$2.0M
A MIR-486/DOCK3 SIGNALING AXIS MODULATES DYSTROPHIN-DEFICIENT PATHOLOGYR01HD095897 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ALEXANDER, MATTHEW SCOTT · 2018 to 2022
$1.6M
UAB Training Program In NeuroscienceT32NS095775 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Erik D Roberson · 2017 to 2026
$1.6M
Smad8 is a driver of Duchenne muscular dystrophy pathology via myomiR repressionK08NS120812 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LOPEZ, MICHAEL ALONZO · 2021 to 2025
$1.1M
Micro RNAs as biomarkers and therapeutic targets in myotubular myopathyR21AR074006 · NIAMS · HOSPITAL FOR SICK CHLDRN (TORONTO) · PI ALEXANDER, MATTHEW SCOTT, DOWLING, JAMES J · 2018 to 2019
$337k
NCI NIH HHS P30 CA008748NHLBI NIH HHS R01 HL135564NHLBI NIH HHS R01 HL153501NHLBI NIH HHS R03 HL141620NIAMS NIH HHS R21 AR074006NIAMS NIH HHS U01 AR071133NICHD NIH HHS P2C HD086851NICHD NIH HHS R01 HD095897NIDDK NIH HHS P30 DK056336NIGMS NIH HHS R01 GM083300NIGMS NIH HHS R35 GM140710NINDS NIH HHS F99 NS118718NINDS NIH HHS K08 NS120812NINDS NIH HHS T32 NS095775
6 · The paper itself

Abstract

miR-486 is a muscle-enriched microRNA, or "myomiR," that has reduced expression correlated with Duchenne muscular dystrophy (DMD). To determine the function of miR-486 in normal and dystrophin-deficient muscles and elucidate miR-486 target transcripts in skeletal muscle, we characterized

Indexed as

DystrophinMicroRNAsAnimalsMiceMice, Inbred mdxMuscle, SkeletalTranscriptomeDystrophinMicroRNAsMIRN486 microRNA, mouse

Identifiers

PMID35512829
PMCPMC9087951
OpenAlexW4229024308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.